Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Expo East New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Cranberry, probiotics formulations join Kyo-Dophilus line: Product launches at the Natural Products Expo East trade show and conference, Oct. 13-16 in Boston, include Wakunga of America's debut of two probiotic formulations. Kyo-DophilusProbiotics plus fiber "provides 1 billion live cells from three different probiotic strains to replenish and restore natural flora," the Mission Viejo, Calif., company says. In addition to probiotic strains L. gasseri, B. bifdum and B. longum, the product also contains prebiotic inulin fiber for intestinal support. The firm suggests a retail price of $19.95. Wakunga also introduces Kyo-Dophilusplus Cranberry Extract designed to promote urinary tract and intestinal health. It contains probiotics and the patented Bio-Shield technology "that protects the cranberry from destruction by gastric acid, allowing it to be absorbed through the intestinal wall," the company says. The product, with a suggested price of $21.95, is shelf stable and does not require refrigeration

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts